Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
EXPAREL132M78.31%
ZILRETTA28.42M16.86%
iovera°5.66M3.35%
Bupivacaine liposome injectable suspension1.64M0.97%
Royalty revenue851K0.50%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
U.S., European Union (E.U.) and United Kingdom (U.K)538.12M79.72%
United States111.1M16.46%
U.S., Canada and Europe19.69M2.92%
Bupivacaine liposome injectable suspension3.34M0.50%
Royalty revenue2.73M0.40%
